Skip to main content
. 2020 Dec 30;13(1):87. doi: 10.3390/cancers13010087

Figure 1.

Figure 1

Comparison of muscle-invasive bladder cancer (MIBC) subtype frequency in patient tumours and human bladder cancer (BCa) cell lines used in radiotherapy (RT) experimental studies in vitro and preclinical studies in vivo. (a) MIBC tumour subtypes (classified by [36]); (b) cell line subtypes used in experimental studies of RT in BCa in vitro (classified by [46]); (c) cell line subtypes used in preclinical studies of radiotherapy in BCa in vivo (mice xenografts) (classified by [46]).